Evidence map›Paper›PMID 34565798›Full record

ArticleEuropean journal of human genetics : EJHG2022

Correction: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone).

Maja Matic, Marga Nijenhuis, Bianca Soree, Nienke J de Boer-Veger, Anne-Marie Buunk, Elisa J F Houwink, Hans Mulder, Gerard A P J M Rongen, Jan van der Weide, Bob Wilffert and 4 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of human genetics : EJHG, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Maja MaticDepartment of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands.
Marga NijenhuisRoyal Dutch Pharmacists Association (KNMP), The Hague, The Netherlands. M.Nijenhuis@knmp.nl.ORCID http://orcid.org/0000-0001-7476-6867
Bianca SoreeRoyal Dutch Pharmacists Association (KNMP), The Hague, The Netherlands.
Nienke J de Boer-VegerPharmacy Boterdiep, Groningen, The Netherlands.
Anne-Marie BuunkPharmacy De Katwijkse Apotheek, Katwijk, The Netherlands.
Elisa J F HouwinkDepartment of Public Health and Primary Care (PHEG), Leiden University Medical Centre, Leiden, The Netherlands.
Hans MulderDepartment of Clinical Pharmacy, Wilhelmina Hospital, Assen, The Netherlands.
Gerard A P J M RongenDepartment of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Jan van der WeideDepartment of Clinical Chemistry, St. Jansdal Hospital, Harderwijk, The Netherlands.
Bob WilffertDepartment of Clinical Pharmacy & Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Jesse J SwenDepartment of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
Henk-Jan GuchelaarDepartment of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
Vera H M DeneerDepartment of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands.
Ron H N van SchaikDepartment of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34565798
PMCPMC9553971

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.